Denali Therapeutics Inc. (DNLI) /
The revenue of Denali Therapeutics Inc. over the past 10 years
Chart Denali Therapeutics Inc.: revenue, fiscal 2016–2025 Open the chart →Denali Therapeutics Inc. reported revenue of $0 in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $0. Year over year, revenue rose 4 times and fell 3 times. In these years the highest was $335.66M in fiscal 2020. The largest one-year move was in fiscal 2020: up 1158%, from $26.68M to $335.66M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $0 |
| 2024ended Dec 31, 2024 | $0 |
| 2023ended Dec 31, 2023 | $330.53M |
| 2022ended Dec 31, 2022 | $108.46M |
| 2021ended Dec 31, 2021 | $48.66M |
| 2020ended Dec 31, 2020 | $335.66M |
| 2019ended Dec 31, 2019 | $26.68M |
| 2018ended Dec 31, 2018 | $129.16M |
| 2017ended Dec 31, 2017 | $0 |
| 2016ended Dec 31, 2016 | $0 |
Fiscal years as Denali Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Denali Therapeutics Inc.
- The profitability of Denali Therapeutics Inc.
- The cash flow of Denali Therapeutics Inc.
- The debt of Denali Therapeutics Inc.
- All of Denali Therapeutics Inc.'s financials, charted
Companies of a similar size
- STEPSTEPSTONE GROUP INC.
- GNWGENWORTH FINANCIAL, INC.
- TNKTEEKAY TANKERS LTD.
- COCOThe Vita Coco Company, Inc.
- LMNDLemonade, Inc.
Not investment advice. This page shows what Denali Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.